We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Image: Bigstock
Small-Cap Growth ETF (IJT) Hits New 52-Week High
For investors seeking momentum, iShares S&P Small-Cap 600 Growth ETF (IJT - Free Report) is probably on the radar now. The fund just hit a 52-week high and is up nearly 35.4% from its 52-week low price of $149.00/share.
But are more gains in store for this ETF? Let’s take a quick look at the fund and the near-term outlook on it to get a better idea on where it might be headed.
IJT in Focus
The fund measures the performance of the small-capitalization growth sector of the U.S. equity market. Ligand Pharmaceuticals, Trex and Healthequity are the top three holdings of the fund. Industrials (21.74%), Health Care (19.02%), Information Technology (16.30%), Financials (13.39%) and Consumer Discretionary (12.53%) are the top five sectors of the fund. The product charges 25 bps in fees (see all Small Cap ETFs here).
Why the Move?
The present economic momentum is solid in the United States with the tax reform underway and several U.S. economic data coming in better than other developed economies. An improving U.S. economy, a rising greenback and geopolitical concerns pushed investors toward the more domestically-focused small-cap stocks. All these have boosted this small-cap ETF.
More Gains Ahead?
The fund has a Zacks Rank #1 (Strong Buy). Plus, it seems that the fund will perform decently in the near term given a positive weighted alpha of 33.40.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>